ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu +10 more
wiley +1 more source
Systematic analysis of adverse reactions associated with dantrolene treatment: From clinical features to molecular mechanisms. [PDF]
Chen H, Zhang X, Chen D, Jiang X, Yu C.
europepmc +1 more source
Distribuert ressurskontroll i en høytilgjengelig database
Magnus Solberg, Even Aasland
openalex +1 more source
Diagnostic Utility of the ATG9A Ratio in AP‐4–Associated Hereditary Spastic Paraplegia
ABSTRACT Adaptor protein complex 4–associated hereditary spastic paraplegia (AP‐4‐HSP), a childhood‐onset neurogenetic disorder and frequent mimic of cerebral palsy, is caused by biallelic variants in the adaptor protein complex 4 (AP‐4) subunit genes (AP4B1 [for SPG47], AP4M1 [for SPG50], AP4E1 [for SPG51], and AP4S1 [for SPG52]).
Habibah A. P. Agianda +12 more
wiley +1 more source
Using administrative data to predict the outcomes of prematurity (EB-POC): a protocol for a linkage study from an Australian Neonatal Network. [PDF]
Abdel-Latif M +3 more
europepmc +1 more source
Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy
ABSTRACT Adrenoleukodystrophy is a rare inherited peroxisomal disease caused by pathogenic variants in the ABCD1 gene located on the X chromosome. Although the most severe central nervous system and adrenal complications typically affect only men with adrenoleukodystrophy, the majority of women develop myeloneuropathy symptoms in adulthood.
Chenwei Yan +3 more
wiley +1 more source
Characterization of ocular adverse events associated with crizotinib: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase. [PDF]
Dong S, Jiang ZC, Gao L, Zhang R, Liu Y.
europepmc +1 more source
Application of network pharmacology in traditional Chinese medicine for the treatment of cardiac diseases. [PDF]
Zhai X, Chen X, Xiao X, Wu L.
europepmc +1 more source

